- Home
- MGYR vs ANVS Comparison
MGYR vs ANVS Comparison
Compare MGYR & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGYR | ANVS |
|---|---|---|
| Founded | 1922 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.2M | 111.3M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MGYR | ANVS |
|---|---|---|
| Price | $17.95 | $2.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 3.6K | ★ 314.1K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | 26.83 | ★ 62.92 |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $34.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.52 | $1.11 |
| 52 Week High | $20.00 | $5.50 |
Technical Indicators
Market Signals| Indicator | MGYR | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.74 | 46.57 |
| Support Level | $17.07 | $2.27 |
| Resistance Level | $17.87 | $2.63 |
| Average True Range (ATR) | 0.29 | 0.19 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 30.50 | 34.62 |
Price Performance
Historical ComparisonAbout MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.